Workplace social capital and adherence to antihypertensive medication: A cohort study

Tuula Oksanen, Ichiro Kawachi, Anne Kouvonen, Etsuji Suzuki, Soshi Takao, Noora Sjösten, Marianna Virtanen, Jaana Pentti, Jussi Vahtera, Mika Kivimäki

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background: While hypertension is a common and treatable health problem, adherence to antihypertensive medication remains a challenge. This study examines the hypothesis that workplace social capital may influence adherence to antihypertensive medication among hypertensive employees. Methodology/Principal Findings: We linked survey responses to nationwide pharmacy records for a cohort of 3515 hypertensive employees (mean age 53.9 years, 76% women) who required continuous antihypertensive drug therapy (the Finnish Public Sector study). A standard scale was used to measure workplace social capital from co-workers' assessments and self-reports in 2000-2004. Non-adherence to antihypertensive medication was determined based on the number of days-not-treated at the year following the survey using comprehensive prescription records. Negative binomial regression models were conducted adjusting for socio-demographic characteristics, duration of hypertension, behaviour-related risk factors, and co-morbid conditions. The overall rate of days-not-treated was 20.7 per person-year (78% had no days-not-treated). Higher age, obesity, and presence of somatic co-morbidities were all associated with better adherence, but this was not the case for co-worker-assessed or self-reported workplace social capital. The rate of days-not-treated was 19.7 per person-year in the bottom fourth of co-worker-assessed workplace social capital, compared to 20.4 in the top fourth. The corresponding rate ratio from the fully-adjusted model was 0.95 (95% confidence interval (CI) 0.58-1.56). In a subgroup of 907 new users of antihypertensive medication this rate ratio was 0.98 (95% CI 0.42-2.29). Conclusions/Significance: We found no consistent evidence to support the hypothesized effect of workplace social capital on adherence to drug therapy among employees with chronic hypertension.

Original languageEnglish
Article numbere24732
JournalPLoS One
Volume6
Issue number9
DOIs
Publication statusPublished - Sep 9 2011

Fingerprint

social capital
antihypertensive agents
working conditions
cohort studies
Workplace
Antihypertensive Agents
drug therapy
Cohort Studies
Drug therapy
human resources
hypertension
Personnel
Hypertension
confidence interval
Confidence Intervals
Drug Therapy
Public Sector
Statistical Models
Medical problems
public sector

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Workplace social capital and adherence to antihypertensive medication : A cohort study. / Oksanen, Tuula; Kawachi, Ichiro; Kouvonen, Anne; Suzuki, Etsuji; Takao, Soshi; Sjösten, Noora; Virtanen, Marianna; Pentti, Jaana; Vahtera, Jussi; Kivimäki, Mika.

In: PLoS One, Vol. 6, No. 9, e24732, 09.09.2011.

Research output: Contribution to journalArticle

Oksanen, T, Kawachi, I, Kouvonen, A, Suzuki, E, Takao, S, Sjösten, N, Virtanen, M, Pentti, J, Vahtera, J & Kivimäki, M 2011, 'Workplace social capital and adherence to antihypertensive medication: A cohort study', PLoS One, vol. 6, no. 9, e24732. https://doi.org/10.1371/journal.pone.0024732
Oksanen, Tuula ; Kawachi, Ichiro ; Kouvonen, Anne ; Suzuki, Etsuji ; Takao, Soshi ; Sjösten, Noora ; Virtanen, Marianna ; Pentti, Jaana ; Vahtera, Jussi ; Kivimäki, Mika. / Workplace social capital and adherence to antihypertensive medication : A cohort study. In: PLoS One. 2011 ; Vol. 6, No. 9.
@article{d35eb576d5104c46882d6be4516c53f0,
title = "Workplace social capital and adherence to antihypertensive medication: A cohort study",
abstract = "Background: While hypertension is a common and treatable health problem, adherence to antihypertensive medication remains a challenge. This study examines the hypothesis that workplace social capital may influence adherence to antihypertensive medication among hypertensive employees. Methodology/Principal Findings: We linked survey responses to nationwide pharmacy records for a cohort of 3515 hypertensive employees (mean age 53.9 years, 76{\%} women) who required continuous antihypertensive drug therapy (the Finnish Public Sector study). A standard scale was used to measure workplace social capital from co-workers' assessments and self-reports in 2000-2004. Non-adherence to antihypertensive medication was determined based on the number of days-not-treated at the year following the survey using comprehensive prescription records. Negative binomial regression models were conducted adjusting for socio-demographic characteristics, duration of hypertension, behaviour-related risk factors, and co-morbid conditions. The overall rate of days-not-treated was 20.7 per person-year (78{\%} had no days-not-treated). Higher age, obesity, and presence of somatic co-morbidities were all associated with better adherence, but this was not the case for co-worker-assessed or self-reported workplace social capital. The rate of days-not-treated was 19.7 per person-year in the bottom fourth of co-worker-assessed workplace social capital, compared to 20.4 in the top fourth. The corresponding rate ratio from the fully-adjusted model was 0.95 (95{\%} confidence interval (CI) 0.58-1.56). In a subgroup of 907 new users of antihypertensive medication this rate ratio was 0.98 (95{\%} CI 0.42-2.29). Conclusions/Significance: We found no consistent evidence to support the hypothesized effect of workplace social capital on adherence to drug therapy among employees with chronic hypertension.",
author = "Tuula Oksanen and Ichiro Kawachi and Anne Kouvonen and Etsuji Suzuki and Soshi Takao and Noora Sj{\"o}sten and Marianna Virtanen and Jaana Pentti and Jussi Vahtera and Mika Kivim{\"a}ki",
year = "2011",
month = "9",
day = "9",
doi = "10.1371/journal.pone.0024732",
language = "English",
volume = "6",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "9",

}

TY - JOUR

T1 - Workplace social capital and adherence to antihypertensive medication

T2 - A cohort study

AU - Oksanen, Tuula

AU - Kawachi, Ichiro

AU - Kouvonen, Anne

AU - Suzuki, Etsuji

AU - Takao, Soshi

AU - Sjösten, Noora

AU - Virtanen, Marianna

AU - Pentti, Jaana

AU - Vahtera, Jussi

AU - Kivimäki, Mika

PY - 2011/9/9

Y1 - 2011/9/9

N2 - Background: While hypertension is a common and treatable health problem, adherence to antihypertensive medication remains a challenge. This study examines the hypothesis that workplace social capital may influence adherence to antihypertensive medication among hypertensive employees. Methodology/Principal Findings: We linked survey responses to nationwide pharmacy records for a cohort of 3515 hypertensive employees (mean age 53.9 years, 76% women) who required continuous antihypertensive drug therapy (the Finnish Public Sector study). A standard scale was used to measure workplace social capital from co-workers' assessments and self-reports in 2000-2004. Non-adherence to antihypertensive medication was determined based on the number of days-not-treated at the year following the survey using comprehensive prescription records. Negative binomial regression models were conducted adjusting for socio-demographic characteristics, duration of hypertension, behaviour-related risk factors, and co-morbid conditions. The overall rate of days-not-treated was 20.7 per person-year (78% had no days-not-treated). Higher age, obesity, and presence of somatic co-morbidities were all associated with better adherence, but this was not the case for co-worker-assessed or self-reported workplace social capital. The rate of days-not-treated was 19.7 per person-year in the bottom fourth of co-worker-assessed workplace social capital, compared to 20.4 in the top fourth. The corresponding rate ratio from the fully-adjusted model was 0.95 (95% confidence interval (CI) 0.58-1.56). In a subgroup of 907 new users of antihypertensive medication this rate ratio was 0.98 (95% CI 0.42-2.29). Conclusions/Significance: We found no consistent evidence to support the hypothesized effect of workplace social capital on adherence to drug therapy among employees with chronic hypertension.

AB - Background: While hypertension is a common and treatable health problem, adherence to antihypertensive medication remains a challenge. This study examines the hypothesis that workplace social capital may influence adherence to antihypertensive medication among hypertensive employees. Methodology/Principal Findings: We linked survey responses to nationwide pharmacy records for a cohort of 3515 hypertensive employees (mean age 53.9 years, 76% women) who required continuous antihypertensive drug therapy (the Finnish Public Sector study). A standard scale was used to measure workplace social capital from co-workers' assessments and self-reports in 2000-2004. Non-adherence to antihypertensive medication was determined based on the number of days-not-treated at the year following the survey using comprehensive prescription records. Negative binomial regression models were conducted adjusting for socio-demographic characteristics, duration of hypertension, behaviour-related risk factors, and co-morbid conditions. The overall rate of days-not-treated was 20.7 per person-year (78% had no days-not-treated). Higher age, obesity, and presence of somatic co-morbidities were all associated with better adherence, but this was not the case for co-worker-assessed or self-reported workplace social capital. The rate of days-not-treated was 19.7 per person-year in the bottom fourth of co-worker-assessed workplace social capital, compared to 20.4 in the top fourth. The corresponding rate ratio from the fully-adjusted model was 0.95 (95% confidence interval (CI) 0.58-1.56). In a subgroup of 907 new users of antihypertensive medication this rate ratio was 0.98 (95% CI 0.42-2.29). Conclusions/Significance: We found no consistent evidence to support the hypothesized effect of workplace social capital on adherence to drug therapy among employees with chronic hypertension.

UR - http://www.scopus.com/inward/record.url?scp=80052596479&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052596479&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0024732

DO - 10.1371/journal.pone.0024732

M3 - Article

C2 - 21931836

AN - SCOPUS:80052596479

VL - 6

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 9

M1 - e24732

ER -